[cytotoxic alkylating agent used as an antineoplastic primarily for treatment of malignant melanoma and in combination chemotherapy for Hodgkin's disease and sarcomas; administered intravenously; abbreviated DTIC. ( CSP )]
UMLS (NCI) C0010927 - Organic Chemical
- Pharmacologic Substance
Relation/PAR: [AN000] ANTINEOPLASTICS
imidazole
Triazene Compound
imidazole carboxamide
Relation/CHD: 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide
DACARBAZINE 100 MG
DACARBAZINE 200 MG